Abstract 6806: Deciphering the role of BRD2 in acute adaptive response to BET inhibitors across cancers
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-6806
Abstract: Bromodomain and extraterminal motif (BET) inhibitors, such as JQ1, are a promising therapeutic strategy against cancer, targeting key epigenetic regulators, particularly BRD4. However, resistance to BET inhibitors poses a significant challenge, necessitating a deeper understanding… read more here.
Keywords: cancer; brd2; response bet; bet inhibitors ... See more keywords